| Patient | Howard Hughes |
|---|---|
| Date of birth | 1905-12-24 |
| Identifiers | MRN HR-ML006-SYN-TD; SSN (made up) 000-06-5571 |
| Document date | 1947-09-14 |
| Author | Anselm Garrity-Moyo, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Periodic adult preventive visit. [S]
Mr. Hughes is a 41-year-old man with obsessive-compulsive disorder on sertraline 200 mg and exposure and response prevention, opioid use disorder on buprenorphine with naloxone, chronic pain after a plane crash, and noise-induced hearing loss with new hearing aids, who comes for his yearly preventive visit three weeks before his twenty-two-week review. He completed the health risk assessment in the waiting room, which he could not have done at intake, and sat in the shared chairs. His washing and checking now take about one and a half hours a day. He has used no opioid other than buprenorphine. He wears his hearing aids every day. He has had no fever or cough since his bronchitis cleared. He cannot recall any vaccines since the crash. [S]
| Element | Detail |
|---|---|
| Visit | Periodic adult preventive visit, age 41 |
| OCD | Rituals about one and a half hours a day; Y-BOCS 17 today |
| Opioids | Buprenorphine 8 mg twice daily; no other opioid use |
| Mood | PHQ-2 0 |
| Medicines | Sertraline 200 mg daily; buprenorphine with naloxone 8 mg twice daily; acetaminophen 1,000 mg three times daily; naloxone nasal spray on hand |
Health risk assessment. Completed on paper in the waiting room and reviewed with the patient by Dr. Garrity-Moyo. [S]
| Domain | Finding |
|---|---|
| Self-rated health | Good, and better than in the spring |
| Psychosocial | Weekly exposure therapy; working longer days; still prefers to meet few people |
| Substance use | In treatment for opioid use disorder on buprenorphine; AUDIT-C 1 at intake |
| Tobacco | Never smoked |
| Physical activity | Physical therapy exercises daily and walks most days |
| Nutrition | Three meals a day, including food his cook prepares without his watching |
| Sleep | Six to seven hours |
| Safety at home | Feels safe; no firearms in the home; naloxone in the house |
| Road and air safety | Wears a seat belt; wears hearing protection when flying |
| Activities of daily living | Independent |
| Hearing and vision | Hearing aids daily; no vision problems |
| System | Result | Finding |
|---|---|---|
| Constitutional | Negative | No fever or night sweats; weight rising as planned |
| Eyes | Negative | No vision change |
| Ears, nose, mouth, and throat | Positive | Hearing loss, helped by hearing aids; no tinnitus or ear pain |
| Cardiovascular | Negative | No chest pain apart from the old chest wall pain, no palpitations |
| Respiratory | Negative | Cough resolved; no shortness of breath |
| Gastrointestinal | Negative | No constipation on buprenorphine; no blood in the stool |
| Genitourinary | Negative | No urinary symptoms |
| Musculoskeletal | Positive | Chest wall, left shoulder and low back pain, milder than in the spring |
| Skin | Negative | Hands no longer cracked from washing |
| Neurological | Negative | No headaches, weakness or numbness |
| Psychiatric | Positive | Contamination fears milder; mood good; no thoughts of suicide or of harming anyone |
11 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Acetaminophen 300 mg with codeine 30 mg oral tablet, prescribed elsewhere since the crash as one or two tablets every 6 hours as needed, no more than 8 a day; he has been taking 10 to 12 a day | One or two tablets every 6 hours as needed, no more than 8 a day | Oral route | 1947-05-04 to 1947-05-11 | completed | S |
| Naloxone 4 mg nasal spray, one spray into one nostril for a suspected opioid overdose, repeated every two to three minutes in the other nostril if needed; two-pack dispensed, with instruction for him and his household staff | One spray as needed for suspected overdose; repeat in 2 to 3 minutes if needed | Nasal route | 1947-05-04 | active | S |
| Buprenorphine 2 mg with naloxone 0.5 mg sublingual film for the first day: 4 mg once withdrawal is moderate (COWS 12 or more), then 2 to 4 mg every one to two hours as needed, to no more than 16 mg on the first day | First-day induction by the written plan, no more than 16 mg | Sublingual route | 1947-05-11 to 1947-05-12 | completed | S |
| Buprenorphine 8 mg with naloxone 2 mg sublingual film, one film twice daily (16 mg a day), for opioid use disorder and pain; dispensed one week at a time at first | One film under the tongue twice daily | Sublingual route | 1947-05-12 | active | S |
| Acetaminophen 500 mg oral tablet, two tablets three times daily (3,000 mg a day) for pain after the crash, now that codeine combination tablets have stopped | Two tablets three times daily, no more than 3,000 mg a day | Oral route | 1947-05-11 | active | S |
| Sertraline 50 mg oral tablet, one tablet daily | One tablet daily | Oral route | 1947-05-11 to 1947-06-08 | completed | S |
| Sertraline 100 mg oral tablet, one tablet daily | One tablet daily | Oral route | 1947-06-08 to 1947-07-13 | completed | S |
| Sertraline 100 mg oral tablet, two tablets daily (200 mg), the usual target range for OCD | Two tablets daily | Oral route | 1947-07-13 | active | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 1947-09-14 | Body height | 191 | cm | S |
| 1947-09-14 | Body weight | 75.6 | kg | S |
| 1947-09-14 | Body mass index (BMI) [Ratio] | 20.7 | kg/m2 | S |
| 1947-09-14 | Systolic blood pressure | 116 | mm[Hg] | S |
| 1947-09-14 | Diastolic blood pressure | 74 | mm[Hg] | S |
| 1947-09-14 | Heart rate | 70 | /min | S |
| 1947-09-14 | Respiratory rate | 14 | /min | S |
| 1947-09-14 | Body temperature | 36.6 | Cel | S |
| 1947-09-14 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 1947-09-14 | Cholesterol [Mass/volume] in Serum or Plasma | 182 | mg/dL | <=199 mg/dL | Normal | S |
| 1947-09-14 | Cholesterol in HDL [Mass/volume] in Serum or Plasma | 52 | mg/dL | >=40 mg/dL | Normal | S |
| 1947-09-14 | Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation | 112 | mg/dL | <=129 mg/dL | Normal | S |
| 1947-09-14 | Triglyceride [Mass/volume] in Serum or Plasma | 90 | mg/dL | <=149 mg/dL | Normal | S |
| 1947-09-14 | Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] | 0 | {score} | S |
Vital signs recorded on 1947-09-14; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| Constitutional | Well; weight 75.6 kg, BMI 20.7; blood pressure 116/74; pulse 70 |
| Ears, nose, mouth, and throat | Hearing aids in place; canals clear; teeth and gums healthy |
| Neck | No thyroid enlargement or nodes |
| Cardiovascular | Regular rhythm; no murmur |
| Respiratory | Clear to auscultation; healed scars on the chest wall |
| Abdomen | Soft and non-tender |
| Skin | Healed burn scars; hands no longer cracked |
| Psychiatric | Calm and engaged; shook hands at the end of the visit |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Intrusive fears of contamination by germs for about a year, worse since the crash, with hand washing, cleaning of objects and avoidance of handshakes, shared spaces and food handled by others, taking about four hours a day; he recognizes the fears are probably excessive; cause under evaluation | resolved | confirmed | R46.81 | S — Synthetic presenting problem anchored to his documented fear of germs; resolved into the diagnosis of OCD at the consultation. Not a claim about his real symptoms in 1947. |
| Obsessive-compulsive disorder, contamination type, with good or fair insight, not tic-related; Y-BOCS 28 (severe) at intake; no post-traumatic stress disorder on screening | active | confirmed | F42.2 | S — Synthetic modern diagnosis made at the consultation, linked to the retrospective interpretation of his documented fears (R). Not a claim about his real diagnosis. |
| Opioid use disorder, moderate (four of the DSM-5-TR criteria that count for a prescribed opioid: taking more than prescribed, failed attempts to cut down, time spent getting prescriptions from two prescribers, and craving), on codeine prescribed after a crash; buprenorphine planned | active | confirmed | F11.20 | S — Synthetic modern coding; tolerance and withdrawal are not counted for a medicine taken under medical supervision. Person-first language; not a claim about his real diagnosis. |
| Chronic pain after major trauma ten months ago (crushed chest with rib fractures, collapsed lung, other fractures and burns): chest wall, left shoulder and low back pain, PEG 6.7 | active | confirmed | G89.21 | S — Synthetic modern diagnosis anchored to his documented injuries. |
| Difficulty hearing conversation, worse in noise, after years of flying in loud aircraft; cause under evaluation | resolved | confirmed | H91.93 | S — Synthetic presenting problem; resolved into a diagnosis when audiometry was done at five weeks. His documented deafness is from later years. |
| Bilateral high-frequency sensorineural hearing loss with a notch at 4000 Hz, consistent with noise exposure from flying; hearing aids fitted | active | confirmed | H90.3 | S — Synthetic modern diagnosis made at five weeks; not a claim about his real hearing in 1947. |
| Weight loss of about 8 kg since the crash (BMI 19.7), from eating little outside food he has prepared or inspected himself because of contamination fears | active | confirmed | R63.4 | S — Synthetic nutrition problem linked to the contamination fears; not a claim about his real weight in 1947. |
| Acute bronchitis, likely viral, for five days; no pneumonia on examination; resolved within three weeks without antibiotics | resolved | confirmed | J20.9 | S — Synthetic acute illness; not a historical claim. |
Personalized prevention plan. A written copy was given to the patient. [S]
| Service | Status | Detail |
|---|---|---|
| Blood pressure | Completed today | 116/74 mmHg |
| Lipid screening and cardiovascular risk | Completed today | LDL 112 mg/dL; low 10-year risk; statin not indicated |
| Diabetes screening | Not indicated | Recommended for adults 35 to 70 with overweight or obesity; his BMI is 20.7 |
| Colorectal cancer screening | Not indicated | Begins at 45; no family history recorded |
| Lung cancer screening | Not indicated | Never smoked |
| HIV screening | Up to date | Negative at intake |
| Hepatitis C screening | Up to date | Antibody negative at intake |
| Hepatitis B screening | Up to date | Triple panel at intake: not infected and not immune |
| Depression screening | Completed today | PHQ-2 0 |
| Unhealthy drug use | Up to date | In treatment for opioid use disorder |
| Unhealthy alcohol use | Up to date | AUDIT-C 1 at intake; advised to keep alcohol low with buprenorphine |
| Hearing | Up to date | Audiogram at five weeks; hearing aids fitted at ten weeks |
| Influenza vaccine | Completed today | Vaccine for the coming season given today |
| Tetanus, diphtheria, and pertussis | Completed today | Tdap today; no booster recorded since the crash |
| Hepatitis B vaccine | Completed today | First of two HepB-CpG doses; second in one month or more |
| COVID-19 vaccine | Due | Recommended for the coming season; he chose to have it at his next visit rather than a fourth injection today |
Immunizations given today: Influenza vaccine for the coming season; Tdap vaccine; no tetanus booster recorded since the crash; Hepatitis B vaccine (HepB-CpG), first of two doses; not immune at intake [S]
Guideline basis: VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024); CMID: Clinical Monitoring Intelligence Database, depression, bipolar, and mood disorders monograph (2026); Medicare Preventive Services reference: visit templates, screening cascades, and documentation elements (2026); USPSTF A and B Recommendations (2026); Adult Immunization Schedule by Age (2026)
Follow-up: Twenty-two-week review in three weeks with laboratory tests. Second hepatitis B dose in one month or more; COVID-19 vaccine at the next visit. Next preventive visit in one year. Next scheduled visit 1947-10-05: twenty-two-week review: response of OCD, buprenorphine maintenance, pain, weight and laboratory checks. [S]
Voluntary advance care planning discussion of about 16 minutes, with his consent. He named a health care agent and completed a health care proxy form; the agent is recorded in the chart and is not named here. He said that what matters most to him is privacy, being able to work, and making his own decisions. He would want full treatment for any condition from which he could recover and to be told plainly about his health. He chose not to record other preferences today. The plan will be revisited yearly or after any serious illness or injury. [S]